Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Cardiorenal Medicine
|
May 1, 2020
Adverse Drug Reactions during Real-Life Use of Direct Oral Anticoagulants in Italy: An Update Based on Data from the Italian National Pharmacovigilance Network
Carlo Lavalle, Luca Di Lullo, Antonio Bellasi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
October 1, 2017
[Neprilysin inhibition and chronic kidney disease]
Luca Di Lullo, Claudio Ronco, Antonio Bellasi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
July 9, 2026
[Clinical and Pathophysiological Aspects of the Interactions Between the Thyroid and the Kidney]
Lorenzo D'Elia, Luciano Cencioni, Andrea Dello Strologo, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
April 26, 2022
[Atrial fibrillation, oral anticoagulation and nephroprotection: caution or bravery?]
Luca Di Lullo, Michele Magnocavallo, Giampaolo Vetta, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
January 10, 2014
[Pathophysiology and diagnosis of cardio-renal syndrome: actual picture and future prospectives]
Luca Di Lullo, Fulvio Floccari, Antonio De Pascalis, et al.
International Journal of Cardiology
|
December 13, 2018
Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor
Luca Di Lullo, Giovanni Tripepi, Claudio Ronco, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
July 5, 2016
[Acute Kidney Injury, Type - 3 cardiorenal syndrome, Biomarkers, Renal Replacement Therapy]
Luca Di Lullo, Antonio Bellasi, Vincenzo Barbera, et al.
Journal of Nephrology
|
June 9, 2018
Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data
Luca Di Lullo, Giovanni Tripepi, Claudio Ronco, et al.
Journal of Clinical Medicine
|
December 31, 2020
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
Michele Magnocavallo, Antonio Bellasi, Marco Valerio Mariani, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Cardiorenal Medicine
|
May 1, 2020
Adverse Drug Reactions during Real-Life Use of Direct Oral Anticoagulants in Italy: An Update Based on Data from the Italian National Pharmacovigilance Network
Carlo Lavalle, Luca Di Lullo, Antonio Bellasi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
October 1, 2017
[Neprilysin inhibition and chronic kidney disease]
Luca Di Lullo, Claudio Ronco, Antonio Bellasi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
July 9, 2026
[Clinical and Pathophysiological Aspects of the Interactions Between the Thyroid and the Kidney]
Lorenzo D'Elia, Luciano Cencioni, Andrea Dello Strologo, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
April 26, 2022
[Atrial fibrillation, oral anticoagulation and nephroprotection: caution or bravery?]
Luca Di Lullo, Michele Magnocavallo, Giampaolo Vetta, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
January 10, 2014
[Pathophysiology and diagnosis of cardio-renal syndrome: actual picture and future prospectives]
Luca Di Lullo, Fulvio Floccari, Antonio De Pascalis, et al.
International Journal of Cardiology
|
December 13, 2018
Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor
Luca Di Lullo, Giovanni Tripepi, Claudio Ronco, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
July 5, 2016
[Acute Kidney Injury, Type - 3 cardiorenal syndrome, Biomarkers, Renal Replacement Therapy]
Luca Di Lullo, Antonio Bellasi, Vincenzo Barbera, et al.
Journal of Nephrology
|
June 9, 2018
Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data
Luca Di Lullo, Giovanni Tripepi, Claudio Ronco, et al.
Journal of Clinical Medicine
|
December 31, 2020
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
Michele Magnocavallo, Antonio Bellasi, Marco Valerio Mariani, et al.
Page
of 3